• Return to Headlines

Medicines Comp Shares Up 19.9% Since SmarTrend's Buy Recommendation (MDCO)

By Shiri Gupta

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 6 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

In the past 52 weeks, Medicines Comp share prices have been bracketed by a low of $16.69 and a high of $84.98 and are now at $84.90, 409% above that low price. The 200-day and 50-day moving averages have moved 0% lower and 0% lower over the past week, respectively.

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Medicines Comp shares.

Log in and add Medicines Comp (MDCO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights medicines comp

Ticker(s): MDCO